Equasens Société anonyme Vergangene Ertragsentwicklung
Vergangenheit Kriterienprüfungen 3/6
Equasens Société anonyme hat ein durchschnittliches jährliches Gewinnwachstum von 15.5% verzeichnet, während die Branche Healthcare Services ein Gewinnwachstum gewachsen unter 9.1% jährlich einen Rückgang. Die Umsätze sind gewachsen mit einer durchschnittlichen Rate von 9.6% pro Jahr. Equasens Société anonyme's return on equity is 25%, und die Nettomargen betragen 21.7%.
Wichtige Informationen
15.6%
Wachstumsrate der Gewinne
15.6%
EPS-Wachstumsrate
| Healthcare Services Wachstum der Industrie | 21.0% |
| Wachstumsrate der Einnahmen | 9.3% |
| Eigenkapitalrendite | 21.5% |
| Netto-Marge | 21.4% |
| Nächste Ertragsaktualisierung | 27 Sep 2024 |
Jüngste Aktualisierungen vergangener Leistungen
Recent updates
Is Equasens Société anonyme (EPA:EQS) Using Too Much Debt?
Jun 07
Equasens Société anonyme (EPA:EQS) Is Aiming To Keep Up Its Impressive Returns
Apr 03At €51.10, Is It Time To Put Equasens Société anonyme (EPA:EQS) On Your Watch List?
Mar 08Some Confidence Is Lacking In Equasens Société anonyme's (EPA:EQS) P/E
Feb 14Estimating The Intrinsic Value Of Equasens Société anonyme (EPA:EQS)
Jan 27Should You Investigate Equasens Société anonyme (EPA:EQS) At €59.70?
Nov 29These 4 Measures Indicate That Equasens Société anonyme (EPA:EQS) Is Using Debt Safely
Oct 28A Look At The Intrinsic Value Of Equasens Société anonyme (EPA:EQS)
Sep 27Should You Think About Buying Equasens Société anonyme (EPA:EQS) Now?
Aug 05Equasens Société anonyme (EPA:EQS) Is Increasing Its Dividend To €1.15
Jun 11Equasens Société anonyme's (EPA:EQS) Shareholders Will Receive A Bigger Dividend Than Last Year
May 22Equasens Société anonyme's (EPA:EQS) Shareholders Will Receive A Bigger Dividend Than Last Year
May 08What Does Equasens Société anonyme's (EPA:EQS) Share Price Indicate?
Apr 04Equasens Société anonyme (EPA:EQS) Will Want To Turn Around Its Return Trends
Feb 13Calculating The Intrinsic Value Of Equasens Société anonyme (EPA:EQS)
Jan 26At €71.60, Is Equasens Société anonyme (EPA:EQS) Worth Looking At Closely?
Dec 21Should You Be Adding Equasens Société anonyme (EPA:EQS) To Your Watchlist Today?
Dec 07Here's What's Concerning About Equasens Société anonyme's (EPA:EQS) Returns On Capital
Nov 12Is Equasens Société anonyme (EPA:EQS) Trading At A 26% Discount?
Oct 27Is Equasens Société anonyme (EPA:EQS) Using Too Much Debt?
Oct 12When Should You Buy Equasens Société anonyme (EPA:EQS)?
Sep 09With EPS Growth And More, Equasens Société anonyme (EPA:EQS) Makes An Interesting Case
Aug 24Equasens Société anonyme (EPA:EQS) Might Be Having Difficulty Using Its Capital Effectively
Jul 28Equasens Société anonyme (EPA:EQS) Is Increasing Its Dividend To €1.05
Jun 10Pharmagest Interactive (EPA:PHA) Has Announced That It Will Be Increasing Its Dividend To €1.05
May 27Is Now The Time To Put Pharmagest Interactive (EPA:PHA) On Your Watchlist?
May 22Here's What Pharmagest Interactive's (EPA:PHA) Strong Returns On Capital Mean
Apr 25Are Investors Undervaluing Pharmagest Interactive SA (EPA:PHA) By 28%?
Feb 23Here's Why I Think Pharmagest Interactive (EPA:PHA) Might Deserve Your Attention Today
Feb 09Is Pharmagest Interactive SA (EPA:PHA) Potentially Undervalued?
Jan 25Many Would Be Envious Of Pharmagest Interactive's (EPA:PHA) Excellent Returns On Capital
Jan 06Pharmagest Interactive (EPA:PHA) Could Easily Take On More Debt
Nov 14Is There An Opportunity With Pharmagest Interactive SA's (EPA:PHA) 20% Undervaluation?
Oct 30Is Now The Time To Put Pharmagest Interactive (EPA:PHA) On Your Watchlist?
Sep 28Is Pharmagest Interactive SA (EPA:PHA) Trading At A 20% Discount?
Jul 18Pharmagest Interactive (EPA:PHA) Will Want To Turn Around Its Return Trends
Jun 24Does Pharmagest Interactive (EPA:PHA) Deserve A Spot On Your Watchlist?
Apr 08Pharmagest Interactive SA (EPA:PHA) Is An Attractive Dividend Stock - Here's Why
Mar 24Pharmagest Interactive SA's (EPA:PHA) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Mar 03Our Take On The Returns On Capital At Pharmagest Interactive (EPA:PHA)
Feb 09
Shareholders of Pharmagest Interactive (EPA:PHA) Must Be Delighted With Their 500% Total Return
Jan 12What To Know Before Buying Pharmagest Interactive SA (EPA:PHA) For Its Dividend
Dec 15Are Strong Financial Prospects The Force That Is Driving The Momentum In Pharmagest Interactive SA's EPA:PHA) Stock?
Dec 01Aufschlüsselung der Einnahmen und Ausgaben
Aufschlüsselung der Einnahmen und Ausgaben
Wie Equasens Société anonyme Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.
Gewinn- und Umsatzhistorie
| Datum | Einnahmen | Umsatz | Allgemeine und Verwaltungskosten | F&E-Ausgaben |
|---|---|---|---|---|
| 31 Dec 23 | 220 | 47 | 0 | 0 |
| 30 Jun 23 | 223 | 48 | 0 | 0 |
| 31 Mar 23 | 219 | 47 | 0 | 0 |
| 31 Dec 22 | 214 | 46 | 0 | 0 |
| 30 Jun 22 | 203 | 42 | 0 | 0 |
| 31 Mar 22 | 198 | 41 | 0 | 0 |
| 31 Dec 21 | 193 | 39 | 0 | 0 |
| 30 Sep 21 | 190 | 37 | 0 | 0 |
| 30 Jun 21 | 188 | 35 | 0 | 0 |
| 31 Mar 21 | 180 | 33 | 0 | 0 |
| 31 Dec 20 | 172 | 31 | 0 | 0 |
| 30 Sep 20 | 166 | 29 | 0 | 0 |
| 30 Jun 20 | 160 | 27 | 0 | 0 |
| 31 Mar 20 | 159 | 27 | 0 | 0 |
| 31 Dec 19 | 159 | 27 | 0 | 0 |
| 30 Sep 19 | 156 | 27 | 0 | 0 |
| 30 Jun 19 | 153 | 26 | 0 | 0 |
| 31 Mar 19 | 151 | 26 | 0 | 0 |
| 31 Dec 18 | 148 | 25 | 0 | 0 |
| 30 Sep 18 | 144 | 25 | 0 | 0 |
| 30 Jun 18 | 139 | 24 | 0 | 0 |
| 31 Mar 18 | 134 | 24 | 0 | 0 |
| 31 Dec 17 | 130 | 23 | 0 | 0 |
| 30 Sep 17 | 129 | 22 | 0 | 0 |
| 30 Jun 17 | 128 | 21 | 0 | 0 |
| 31 Mar 17 | 128 | 21 | 0 | 0 |
| 31 Dec 16 | 128 | 21 | 0 | 0 |
| 30 Sep 16 | 125 | 20 | 0 | 0 |
| 30 Jun 16 | 121 | 20 | 0 | 0 |
| 31 Mar 16 | 117 | 19 | 0 | 0 |
| 31 Dec 15 | 113 | 19 | 0 | 0 |
| 30 Sep 15 | 113 | 18 | 0 | 0 |
| 30 Jun 15 | 112 | 18 | 0 | 0 |
| 31 Mar 15 | 113 | 17 | 0 | 0 |
| 31 Dec 14 | 115 | 17 | 0 | 0 |
| 30 Sep 14 | 114 | 17 | 0 | 0 |
| 30 Jun 14 | 113 | 16 | 0 | 0 |
| 31 Mar 14 | 113 | 16 | 0 | 0 |
| 31 Dec 13 | 113 | 16 | 0 | 0 |
| 30 Sep 13 | 113 | 15 | 0 | 0 |
| 30 Jun 13 | 113 | 15 | 0 | 0 |
Qualität der Erträge: EQS hat hohe Qualitätseinkünfte.
Wachsende Gewinnspanne: EQSDie aktuellen Gewinnspannen (21.4%) sind niedriger als im letzten Jahr (21.6%).
Analyse von freiem Cashflow und Gewinn
Analyse des Gewinnwachstums in der Vergangenheit
Ergebnisentwicklung: EQSIn den letzten 5 Jahren sind die Gewinne von 15.5% jährlich gestiegen.
Beschleunigtes Wachstum: EQSDas Gewinnwachstum des Unternehmens im letzten Jahr (14.8%) liegt unter seinem 5-Jahres-Durchschnitt (15.5% pro Jahr).
Erträge im Vergleich zur Industrie: EQS Das Gewinnwachstum im vergangenen Jahr (1.7%) übertraf nicht die Entwicklung der Branche Healthcare Services 8.6%.
Eigenkapitalrendite
Hohe Eigenkapitalrendite: EQSDie Eigenkapitalrendite des Unternehmens (25%) wird als hoch angesehen.